Clinical Trials Browser

Phase 2 × OTHER_GOV × Colonic Neoplasms × Clear all

NCT06218888 2024-01-23

A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases

Phase 2 Not yet recruiting

Gastrointestinal

Colonic Neoplasms

NCT05335460 2022-04-19

To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms

NCT00640081 2021-09-22

Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04475159 2020-07-17

Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial

Phase 2 Unknown

GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT00557102 2012-12-11

ERBIFORT

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00948337 2010-02-26

A Study With Health Educational Material on Health Promotion in Cancer Survivors

Phase 2 Unknown

BreastGastrointestinalHead & Neck

Breast Neoplasms, Colonic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms